HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Suzanne L Topalian Selected Research
Suzanne L Topalian Research Topics
Disease
68
Neoplasms (Cancer)
05/2021 - 01/2002
49
Melanoma (Melanoma, Malignant)
11/2021 - 01/2002
12
Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 01/2002
9
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 07/2010
7
Merkel Cell Carcinoma
01/2021 - 07/2013
4
Body Weight (Weight, Body)
05/2018 - 07/2003
4
Kidney Neoplasms (Kidney Cancer)
01/2016 - 07/2003
4
Prostatic Neoplasms (Prostate Cancer)
10/2014 - 03/2002
4
Colorectal Neoplasms (Colorectal Cancer)
10/2014 - 07/2010
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 07/2017
3
Neoplasm Metastasis (Metastasis)
06/2017 - 07/2009
2
Disease Progression
01/2021 - 04/2014
2
Carcinoma (Carcinomatosis)
11/2019 - 03/2002
2
Fowlpox
04/2006 - 08/2003
2
Thrombocytopenia (Thrombopenia)
04/2005 - 01/2002
2
Lymphopenia (Lymphocytopenia)
04/2005 - 05/2002
1
Squamous Cell Carcinoma of Head and Neck
01/2021
1
Infections
01/2021
1
Vulvar Neoplasms (Vulvar Cancer)
11/2019
1
Skin Neoplasms (Skin Cancer)
11/2018
1
Hodgkin Disease (Hodgkin's Disease)
07/2017
1
Virus Diseases (Viral Diseases)
07/2017
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2010
1
Adenocarcinoma
10/2010
Drug/Important Bio-Agent (IBA)
16
Antigens
IBA
11/2018 - 03/2002
12
Immune Checkpoint Inhibitors
IBA
01/2021 - 04/2012
12
Nivolumab
IBA
01/2021 - 01/2013
10
Peptides (Polypeptides)
IBA
01/2017 - 07/2003
9
Epitopes
IBA
11/2013 - 10/2002
6
Biomarkers (Surrogate Marker)
IBA
05/2021 - 11/2005
6
Proteins (Proteins, Gene)
FDA Link
05/2018 - 03/2002
6
Interleukin-2 (IL2)
IBA
04/2006 - 05/2002
5
B7-H1 Antigen
IBA
01/2020 - 09/2015
5
Antibodies
IBA
11/2018 - 12/2005
5
CTLA-4 Antigen
IBA
01/2016 - 07/2003
5
Vaccines
IBA
07/2015 - 08/2003
5
Ligands
IBA
04/2015 - 06/2012
5
Neoplasm Antigens (Tumor Antigens)
IBA
03/2012 - 05/2002
4
Interferons
IBA
01/2021 - 03/2012
4
pembrolizumab
IBA
01/2021 - 06/2016
4
Ipilimumab
IBA
10/2020 - 05/2006
4
DNA (Deoxyribonucleic Acid)
IBA
07/2013 - 04/2003
4
Monophenol Monooxygenase (Tyrosinase)
IBA
04/2006 - 08/2002
3
Cytokines
IBA
11/2019 - 03/2012
3
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2018 - 10/2006
3
Immunoglobulins (Immunoglobulin)
IBA
07/2015 - 06/2015
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2015 - 05/2002
3
HLA-DR1 Antigen (HLA DR1 Antigen)
IBA
09/2012 - 04/2007
3
Interleukins
IBA
12/2005 - 08/2003
3
HLA-A*02:01 antigen
IBA
11/2005 - 08/2003
2
Transcription Factors (Transcription Factor)
IBA
11/2019 - 07/2017
2
Interleukin-10 (Interleukin 10)
IBA
11/2019 - 09/2015
2
Monoclonal Antibodies
IBA
10/2019 - 09/2005
2
Enzymes
IBA
07/2017 - 10/2002
2
Programmed Cell Death 1 Receptor
IBA
07/2017 - 01/2016
2
Formaldehyde (Formol)
FDA Link
01/2016 - 09/2015
2
Paraffin
IBA
01/2016 - 09/2015
2
Interferon-gamma (Interferon, gamma)
IBA
09/2015 - 07/2015
2
Messenger RNA (mRNA)
IBA
03/2013 - 04/2003
2
Triose-Phosphate Isomerase (Triosephosphate Isomerase)
IBA
09/2012 - 04/2007
2
Histocompatibility Antigens Class II
IBA
09/2012 - 06/2010
2
Phosphopeptides
IBA
06/2010 - 07/2009
2
fludarabine
IBA
04/2005 - 05/2002
2
Autoantigens
IBA
04/2004 - 07/2003
2
Differentiation Antigens
IBA
05/2003 - 10/2002
2
Polynucleotide Adenylyltransferase (Polymerase, Poly A)
IBA
04/2003 - 10/2002
1
Phosphotransferases (Kinase)
IBA
01/2021
1
Carcinogens
IBA
01/2021
1
Solutions
IBA
01/2020
1
Pharmaceutical Preparations
IBA
01/2020
1
Interleukin-27 (Interleukin 27)
IBA
11/2019
1
Mono-S
IBA
11/2019
1
Small Interfering RNA (siRNA)
IBA
11/2019
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
07/2017
1
Interleukin-23 (Interleukin 23)
IBA
07/2017
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
07/2017
1
Disulfides
IBA
01/2017
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2017
1
Glycopeptides
IBA
01/2017
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
07/2015
1
Blocking Antibodies
IBA
02/2015
1
Immunomodulating Agents
IBA
10/2014
1
Circulating Tumor DNA
IBA
01/2014
1
Indicators and Reagents (Reagents)
IBA
01/2014
1
HLA-DR4 Antigen (HLA DR4 Antigen)
IBA
11/2013
1
Azacitidine (5 Azacytidine)
FDA Link
11/2013
1
Ataxia Telangiectasia Mutated Proteins
IBA
06/2012
1
Drug Combinations
IBA
08/2011
1
Dihydrotachysterol (AT 10)
IBA
07/2010
1
Mitochondrial DNA (mtDNA)
IBA
06/2008
Therapy/Procedure
34
Therapeutics
11/2021 - 08/2002
26
Immunotherapy
01/2021 - 03/2002
7
Drug Therapy (Chemotherapy)
01/2021 - 05/2002
3
Aftercare (After-Treatment)
01/2020 - 04/2014
2
Neoadjuvant Therapy
01/2021 - 01/2021
2
Castration
10/2014 - 06/2012
2
Intravenous Infusions
07/2010 - 01/2002
2
Intravenous Administration
09/2003 - 01/2002
1
Salvage Therapy
01/2021
1
Investigational Therapies (Experimental Therapy)
11/2013